Mana Capital Acquisition (MAAQ) Competitors $4.58 +0.17 (+3.85%) As of 07/24/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock MAAQ vs. MOLN, JMAC, THTX, LIMN, NKTX, CGEN, LXEO, LYEL, TNYA, and JATTShould you be buying Mana Capital Acquisition stock or one of its competitors? The main competitors of Mana Capital Acquisition include Molecular Partners (MOLN), Maxpro Capital Acquisition (JMAC), Theratechnologies (THTX), Liminatus Pharma (LIMN), Nkarta (NKTX), Compugen (CGEN), Lexeo Therapeutics (LXEO), Lyell Immunopharma (LYEL), Tenaya Therapeutics (TNYA), and JATT Acquisition (JATT). These companies are all part of the "pharmaceutical products" industry. Mana Capital Acquisition vs. Its Competitors Molecular Partners Maxpro Capital Acquisition Theratechnologies Liminatus Pharma Nkarta Compugen Lexeo Therapeutics Lyell Immunopharma Tenaya Therapeutics JATT Acquisition Mana Capital Acquisition (NASDAQ:MAAQ) and Molecular Partners (NASDAQ:MOLN) are both small-cap pharmaceutical products companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, profitability, media sentiment, earnings, dividends, analyst recommendations and institutional ownership. Does the media refer more to MAAQ or MOLN? In the previous week, Molecular Partners had 2 more articles in the media than Mana Capital Acquisition. MarketBeat recorded 2 mentions for Molecular Partners and 0 mentions for Mana Capital Acquisition. Molecular Partners' average media sentiment score of 0.94 beat Mana Capital Acquisition's score of 0.00 indicating that Molecular Partners is being referred to more favorably in the news media. Company Overall Sentiment Mana Capital Acquisition Neutral Molecular Partners Positive Which has higher earnings & valuation, MAAQ or MOLN? Mana Capital Acquisition has higher earnings, but lower revenue than Molecular Partners. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMana Capital AcquisitionN/AN/AN/AN/AN/AMolecular Partners$5.65M28.65-$61.39M-$1.92-2.09 Is MAAQ or MOLN more profitable? Mana Capital Acquisition's return on equity of 0.00% beat Molecular Partners' return on equity.Company Net Margins Return on Equity Return on Assets Mana Capital AcquisitionN/A N/A N/A Molecular Partners N/A -42.20%-38.12% Do insiders and institutionals hold more shares of MAAQ or MOLN? 68.4% of Mana Capital Acquisition shares are owned by institutional investors. Comparatively, 26.6% of Molecular Partners shares are owned by institutional investors. 5.9% of Molecular Partners shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Do analysts prefer MAAQ or MOLN? Molecular Partners has a consensus price target of $12.00, suggesting a potential upside of 199.33%. Given Molecular Partners' stronger consensus rating and higher possible upside, analysts plainly believe Molecular Partners is more favorable than Mana Capital Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mana Capital Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Molecular Partners 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 SummaryMolecular Partners beats Mana Capital Acquisition on 8 of the 11 factors compared between the two stocks. Get Mana Capital Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for MAAQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MAAQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MAAQ vs. The Competition Export to ExcelMetricMana Capital AcquisitionIn Vitro, In Vivo Diagnostic Substances IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$37.21M$37.21M$2.27B$9.50BDividend YieldN/AN/A2.57%4.01%P/E RatioN/AN/A22.0720.05Price / SalesN/AN/A82.5789.38Price / CashN/AN/A29.1858.56Price / BookN/AN/A55.705.87Net IncomeN/AN/A-$121.61M$258.55M7 Day Performance6.51%6.51%0.97%3.73%1 Month Performance30.86%30.86%2.13%11.75%1 Year Performance882.83%882.83%25.21%18.03% Mana Capital Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MAAQMana Capital AcquisitionN/A$4.58+3.9%N/A+847.8%$37.21MN/A0.001Gap UpMOLNMolecular Partners2.5584 of 5 stars$3.63-0.7%$12.00+231.0%-31.5%$147.37M$5.65M-1.89180News CoverageJMACMaxpro Capital AcquisitionN/A$6.45+7.3%N/A+2,900.0%$145.16MN/A0.002,021Gap UpTHTXTheratechnologiesN/A$3.14-0.3%N/A+119.4%$144.61M$85.87M-16.53140Positive NewsLIMNLiminatus PharmaN/A$5.42-0.9%N/AN/A$142.30MN/A0.00N/ANews CoverageGap DownNKTXNkarta1.768 of 5 stars$1.91-4.5%$14.33+650.4%-68.7%$141.91MN/A-1.26140Positive NewsCGENCompugen1.4458 of 5 stars$1.54-3.1%$4.00+159.7%-13.1%$141.89M$27.86M-9.6370LXEOLexeo Therapeutics2.0379 of 5 stars$4.15-2.6%$16.60+300.0%-65.0%$141.42M$650K-1.2658LYELLyell Immunopharma2.5105 of 5 stars$9.24-2.9%$15.00+62.3%-61.9%$140.97M$60K-0.37270News CoverageGap UpTNYATenaya Therapeutics3.9387 of 5 stars$0.88+1.3%$6.25+612.6%-79.1%$140.89MN/A-0.76110Positive NewsJATTJATT AcquisitionN/A$1.96+51.9%N/A-54.6%$140.76MN/A0.003High Trading Volume Related Companies and Tools Related Companies MOLN Alternatives JMAC Alternatives THTX Alternatives LIMN Alternatives NKTX Alternatives CGEN Alternatives LXEO Alternatives LYEL Alternatives TNYA Alternatives JATT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MAAQ) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the coun...Crypto 101 Media | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mana Capital Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mana Capital Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
